Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-14

FDA Approved: LENALIDOMIDE — Original Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

The FDA approved Dr. Reddy's Laboratories' original application for lenalidomide (generic), authorizing a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenalidomide (lenalidomide)

Snippet

ORIG AP for LENALIDOMIDE (LENALIDOMIDE)